PO.TB05.02 · 肿瘤生物学

p14ARF 的转录后沉默驱动 CRISPR 工程化视网膜类器官中视网膜母细胞瘤的恶性转化

Post-transcriptional silencing of p14ARF drives retinoblastoma malignant conversion in CRISPR-engineered retinal organoids

海报缩略图:p14ARF 的转录后沉默驱动 CRISPR 工程化视网膜类器官中视网膜母细胞瘤的恶性转化
编号 6182 展板 18 时间 4/21 02:00–05:00 区域 Section 30 主讲 Jinlun Bai, BA;BS;PhD
分会场 Pediatric Cancer Models
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Jinlun Bai, David S. Koos, Kevin Stachelek, Bhavana Bhat, Susan Asatrian, Patrick Belen, Sunjum Sanghari, Kayla Stepanian, Scott Fraser, Rex A. Moats, David Cobrinik

Children's Hospital Los Angeles, Los Angeles, CA

摘要 Abstract

中文摘要
目的:本研究旨在利用一种 CRISPR 工程化的人视网膜母细胞瘤视网膜类器官(RBRO)模型(该模型再现了视锥细胞起源以及多步骤视网膜母细胞瘤发生的时间进程),阐明驱动从癌前病变发生恶性转化的分子机制。 背景:大多数视网膜母细胞瘤在 RB1 双等位基因失活后由成熟中的视锥光感受器前体细胞(CP)产生。该过程可在离体胎儿视网膜中再现,其中 pRB 缺失的 CP 增殖,随后经历 3-5 个月的静止期,并在与体内疾病相对应的组织年龄出现视网膜母细胞瘤样肿块。CRISPR 工程化的视网膜类器官(RO)为界定恶性进展的潜在机制提供了一个有前景的模型。 方法:我们通过对 GNAT2-EGFP 视锥报告基因进行 CRISPR 编辑(Bai 等,PMID 37902188)生成了 RB1 敲除 iPSC 系。通过混合 RB1 敲除和未编辑的亲本 iPSC 产生嵌合 RBRO。通过对水凝胶包埋的 RBRO 进行活体成像、免疫荧光(IF)染色和深度全长 scRNA-seq,评估 EGFP+ RB1-/- 视锥细胞的增殖动态、细胞身份和细胞状态变化。引入了额外的 CRISPR 编辑以测试静止期进入和逃逸的候选驱动因子。 结果:在 RB1 WT RO 中,EGFP 特异、稳定且无害地标记了有丝分裂后的视锥细胞。在 RBRO 中,活体成像和 IF 染色揭示了初期 EGFP+ RB1-/- 视锥细胞增殖,随后在约 d120 开始进入癌前静止期。大多数最初增殖的视锥细胞变为 Ki67 阴性,部分呈现成熟视锥细胞形态。在约 d280 后形成了由共表达 EGFP、视锥标志物和 Ki67 的细胞组成的视网膜母细胞瘤样病灶,该组织年龄相当于视网膜母细胞瘤出现的出生后第一个月。在不同肿瘤发生阶段的单细胞转录组分析揭示了不同的 RB1-/- 细胞增殖、细胞分化和细胞应激状态,伴有 CDKN2A ARF RNA 和 p14ARF 蛋白的高表达。与最初增殖的静止前 CP 不同,后期增殖的静止后视网膜母细胞瘤样细胞表达 CDKN2A ARF RNA 但不表达 p14ARF 蛋白,这与 p14ARF 转录后沉默作为静止期逃逸机制相一致。缺乏 p14ARF 的 RBRO 表现出持续的初期视锥细胞增殖,类似于逃逸静止期的 p14ARF-WT RBRO。 结论:我们建立了一个人视网膜母细胞瘤类器官模型,再现了多步骤视网膜母细胞瘤发生的细胞起源、发育背景和时间序列。该系统揭示了阶段特异的分子特征,并强调 p53 通路调控——尤其是 p14ARF 的转录后沉默——是静止-恶性转化的关键驱动因素。
查看英文原文 English abstract
Purpose : This study aims to elucidate the molecular mechanisms driving malignant transformation from pre-malignant lesions, leveraging a CRISPR-engineered human retinoblastoma retinal organoid (RBRO) model that recapitulates the cone cell-of-origin and timing of multi-step retinoblastoma genesis. Background : Most retinoblastomas arise from maturing cone photoreceptor precursors (CPs) following biallelic RB1 inactivation. The process can be recapitulated in explanted fetal retina, where pRB-depleted CPs proliferate, followed by a 3-5 month indolence phase and emergence of retinoblastoma-like masses at tissue ages mirroring in vivo disease. CRISPR engineered retinal organoids (ROs) provide a promising model with which to define mechanisms that underlie malignant progression. Methods : We generated RB1 knockout iPSC lines through CRISPR editing of the GNAT2-EGFP cone reporter (Bai et al ., PMID 37902188). Chimeric RBROs were produced by mixing RB1 knockout and unedited parental iPSCs. Proliferation dynamics, cell identities and cell state changes of EGFP+ RB1 -/- cones were evaluated by live imaging of hydrogel-embedded RBROs, immunofluorescent (IF) staining, and deep full-length scRNA-seq. Additional CRISPR edits were introduced to test candidate drivers of indolence entry and escape. Results : In RB1 WT ROs, EGFP specifically, robustly and innocuously labeled post-mitotic cones. In RBROs, live imaging and IF staining revealed initial EGFP+ RB1 -/- cone proliferation followed by a pre-malignant indolence phase starting at ~d120. Most of the initially proliferating cones become Ki67-negative, with some adopting mature cone morphology. Retinoblastoma-like foci composed of cells co-expressing EGFP, cone markers, and Ki67 formed after ~d280, a tissue age that equates to the first post-natal month when retinoblastomas emerge. Single-cell transcriptomic profiling at different tumorigenesis stages revealed distinct RB1 -/- cell proliferation, cell differentiation, and cell stress states with high expression of CDKN2A ARF RNA and p14ARF protein. In contrast to initially proliferating pre-indolence CPs, the later proliferating post-indolence retinoblastoma-like cells expressed CDKN2A ARF RNA but not p14ARF protein, consistent with post-transcriptional silencing of p14ARF as a mechanism underlying indolence escape. RBROs lacking p14ARF exhibited sustained initial cone proliferation similar to indolence-escaped p14ARF-WT RBROs. Conclusion : We established a human retinoblastoma organoid model that recapitulates the cell-of-origin, developmental context, and temporal sequence of multi-step retinoblastoma genesis. This system uncovers stage-specific molecular signatures and highlights p53 pathway regulation - particularly p14ARF post-transcriptional silencing - as a key driver of the indolence-malignancy transition.
利益披露 Disclosure
J. Bai, None.. D. S. Koos, None.. K. Stachelek, None.. B. Bhat, None.. S. Asatrian, None.. P. Belen, None.. S. Sanghari, None.. K. Stepanian, None.. S. Fraser, None.. R. A. Moats, None.. D. Cobrinik, None.

← 返回 AACR 2026 检索